Grant: Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Université de Montréal
$135,000.00
Role of the ribosomal protein RACK1 and protein kinases in a -1 programmed ribosomal frameshift of HIV-1
FY 2009-10
Summary
Viruses are molecular complexes consisting of a nucleic acid of only one type (DNA or RNA) surrounded by a protein coat. Viruses exist in two forms: resting extracellular form (virion) and actively reproducing (replicating) intracellular form. When virus penetrates into the host cell and thus represents the actively replicating form, it needs to produce new copies of its components: nucleic acid and proteins. Proteins are produced inside the host cell by special machinery - the ribosome, which uses the RNA molecule as a template. Production of proteins from a RNA template decodes ("translates") the RNA code into protein. The RNA of Human Immunodeficiency Virus (HIV) also depends on the ribosome to produce all the proteins essential for the viral life cycle. Particular to HIV is that it requires an unusual step during RNA translation into proteins by the ribosome, called the programmed frameshift, for the production of all of its proteins.
Some cellular proteins can modulate synthesis of viral proteins by the ribosome. Our research project aims at studying one of such proteins called RACK1. We will study how RACK1 interacts with the ribosome to modulate synthesis of HIV proteins, and the programmed frameshift, and its quantitative effect on the production of new HIV particles.
Having established the role of RACK1 in synthesis of HIV proteins and in production of new HIV particles, we will be able to designate ways to develop drugs that will block the stimulatory effect of RACK1 on synthesis of viral proteins and, hence, will block HIV replication. Thus, our project will open new avenues for innovative antiretroviral therapy.
Department
Program
Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
194119
Name
Karetnikov Alexey
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Role of the ribosomal protein RACK1 and protein kinases in a -1 programmed ribosomal frameshift of HIV-1
Programtype2
Fellowship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Keyworddelim
Hiv; In Vivo Expression Of Reporter Genes; Molecular Biology; Protein Kinases; Rack1; Retroviruses; Ribosomal E-Site; Ribosomal Frameshift; Sirna-Mediated Knock-Down; Translational Control
Abstract
Viruses are molecular complexes consisting of a nucleic acid of only one type (DNA or RNA) surrounded by a protein coat. Viruses exist in two forms: resting extracellular form (virion) and actively reproducing (replicating) intracellular form. When virus penetrates into the host cell and thus represents the actively replicating form, it needs to produce new copies of its components: nucleic acid and proteins. Proteins are produced inside the host cell by special machinery - the ribosome, which uses the RNA molecule as a template. Production of proteins from a RNA template decodes ("translates") the RNA code into protein. The RNA of Human Immunodeficiency Virus (HIV) also depends on the ribosome to produce all the proteins essential for the viral life cycle. Particular to HIV is that it requires an unusual step during RNA translation into proteins by the ribosome, called the programmed frameshift, for the production of all of its proteins.
Some cellular proteins can modulate synthesis of viral proteins by the ribosome. Our research project aims at studying one of such proteins called RACK1. We will study how RACK1 interacts with the ribosome to modulate synthesis of HIV proteins, and the programmed frameshift, and its quantitative effect on the production of new HIV particles.
Having established the role of RACK1 in synthesis of HIV proteins and in production of new HIV particles, we will be able to designate ways to develop drugs that will block the stimulatory effect of RACK1 on synthesis of viral proteins and, hence, will block HIV replication. Thus, our project will open new avenues for innovative antiretroviral therapy.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Karetnikov, Alexey
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~